Receptor polymorphisms and diseases

Author： Csaszar A.   Abel T.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.414, Iss.1, 2001-02, pp. : 9-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pregnane X receptor polymorphisms associated with human diseases

By Kotta-Loizou Ioly   Patsouris Efstratios   Theocharis Stamatios  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1167-1177

Informa Healthcare

Access to resources Recommend Favorite

Cholecystokinin 1(A) Receptor Polymorphisms

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 12, 2007-06 ,pp. : 1205-1210

Bentham Science Publishers

Access to resources Recommend Favorite

Role of platelet glycoprotein polymorphisms in cardiovascular diseases

By Meisel Christian   López José   Stangl Karl  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 1, 2004-01 ,pp. : 38-54

Springer Publishing Company

Access to resources Recommend Favorite

CCK receptor polymorphisms: an illustration of emerging themes in pharmacogenomics

By Kopin A.S.   McBride E.W.   Schaffer K.   Beinborn M.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 9, 2000-09 ,pp. : 346-353

Elsevier

Access to resources Recommend Favorite

Dopamine receptor polymorphisms and drug response in schizophrenia

By Scharfetter Joachim  

Pharmacogenomics, Vol. 2, Iss. 3, 2001-08 ,pp. : 251-261

Future Medicine

Access to resources Recommend Favorite